Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 18;54(4):779-784.
doi: 10.19723/j.issn.1671-167X.2022.04.033.

[Application of Raman-based technologies in the detection of urological tumors]

[Article in Chinese]
Affiliations

[Application of Raman-based technologies in the detection of urological tumors]

[Article in Chinese]
Z Hao et al. Beijing Da Xue Xue Bao Yi Xue Ban. .

Abstract

Urinary system tumors affect a huge number of individuals, and are frequently recurrent and progressing following surgery, necessitating lifelong surveillance. As a result, early and precise diagnosis of urinary system cancers is important for prevention and therapy. Histopathology is now the golden stan-dard for the diagnosis, but it is invasive, time-consuming, and inconvenient for initial diagnosis and re-gular follow-up assessment. Endoscopy can directly witness the tumor's structure, but intrusive detection is likely to cause harm to the patient's organs, and it is apt to create other hazards in frequently examined patients. Imaging is a valuable non-invasive and quick assessment tool; however, it can be difficult to define the type of lesions and has limited sensitivity for early tumor detection. The conventional approaches for detecting tumors have their own set of limitations. Thus, detection methods that combine non-invasive detection, label-free detection, high sensitivity and high specificity are urgently needed to aid clinical diagnosis. Optical diagnostics and imaging are increasingly being employed in healthcare settings in a variety of sectors. Raman scattering can assess changes in molecular signatures in cancer cells or tissues based on the interaction with vibrational modes of common molecular bonds. Due to the advantages of label-free, strong chemical selectivity, and high sensitivity, Raman scattering, especially coherent Raman scattering microscopy imaging with high spatial resolution, has been widely used in biomedical research. And quantity studies have shown that it has a good application in the detection and diagnosis of bladder can-cer, renal clear cell carcinoma, prostate cancer, and other cancers. In this paper, several nonlinear imaging techniques based on Raman scattering technology are briefly described, including Raman spectroscopy, coherent anti-Stokes Raman scattering, stimulated Raman scattering, and surface-enhanced Raman spectroscopy. And we will discuss the application of these techniques for detecting urologic malignancy. Future research directions are predicted using the advantages and limitations of the aforesaid methodologies in the research. For clinical practice, Raman scattering technology is intended to enable more accurate, rapid, and non-invasive in early diagnosis, intraoperative margins, and pathological grading basis for clinical practice.

Keywords: Diagnosis; Spectrum analysis, Raman; Urologic neoplasms.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Montironi R, Cheng L, Scarpelli M, et al. Pathology and genetics: Tumours of the urinary system and male genital system: Clinical implications of the 4th edition of the WHO classification and beyond. Eur Urol. 2016;70(1):120–123. doi: 10.1016/j.eururo.2016.03.011. - DOI - PubMed
    1. Truong LD, Krishnan B, Shen SS. Intraoperative pathology consultation for kidney and urinary bladder specimens. Arch Pathol Lab Med. 2005;129(12):1585–1601. doi: 10.5858/2005-129-1585-IPCFKA. - DOI - PubMed
    1. Babjuk M, Burger M, Capoun O, et al. European association of urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ) Eur Urol. 2022;81(1):75–94. doi: 10.1016/j.eururo.2021.08.010. - DOI - PubMed
    1. Haka AS, Shafer-Peltier KE, Fitzmaurice M, et al. Diagnosing breast cancer by using Raman spectroscopy. Proc Natl Acad Sci USA. 2005;102(35):12371–12376. doi: 10.1073/pnas.0501390102. - DOI - PMC - PubMed
    1. Fan T, Sun G, Sun X, et al. Tumor energy metabolism and potential of 3-bromopyruvate as an inhibitor of aerobic glycolysis: Implications in tumor treatment. Cancers (Basel) 2019;11(3):317. doi: 10.3390/cancers11030317. - DOI - PMC - PubMed

Substances